Trial Profile
Effect of azacytidine in patients with blastic phase Myeloproliferative Neoplasms
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 May 2015
Price :
$35
*
At a glance
- Drugs Azacitidine (Primary)
- Indications Myeloproliferative disorders
- Focus Therapeutic Use
- 03 May 2015 New trial record